N-Acryloyl-anthranilsaeure | 17090-27-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-Acryloyl-anthranilsaeure
• 英文别名: N-acryloyl-anthranilic acid；acrylamidobenzoic acid；2-(Acryloylamino)benzoic acid；2-(prop-2-enoylamino)benzoic acid
• CAS: 17090-27-6
• 化学式: C₁₀H₉NO₃
• 分子量: 191.186
• InChiKey: KJOLAZDWVDOTSF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-Acryloyl-anthranilsaeure 、 碘甲烷 在 potassium carbonate 作用下， 以67%的产率得到methyl 2-acrylamidobenzoate
  参考文献：
  名称：

  银催化邻氨基苯甲酸和羧酸实际合成 N-酰基邻氨基苯甲酸

  摘要：

  通过银催化从容易获得的邻氨基苯甲酸和羧酸生成亚氨基乙烯酮，实现了有价值的N-酰基邻氨基苯甲酸的实际合成。多种羧酸，包括空间要求高的脂肪族羧酸、芳香族羧酸、丙烯酸和氨基酸，都适合该反应。此外，该方法还可用于修饰药物分子和天然产物，例如布洛芬、丙磺舒和乙酰甘氨酸。

  DOI：

  10.1021/acs.joc.3c02586
• 作为产物：
  描述：

  N-(3-chloro-propionyl)-anthranilic acid 生成 N-Acryloyl-anthranilsaeure
  参考文献：
  名称：

  DE753040

  摘要：

  公开号：

文献信息

• [EN] HETEROCYCLYL SUBSTITUTED PYRROLOPYRIDINES THAT ARE INHIBITORS OF THE CDK12 KINASE<br/>[FR] PYRROLOPYRIDINES À SUBSTITUTION HÉTÉROCYCLYLE UTILISÉES EN TANT QU'INHIBITEURS DE LA KINASE CDK12
  申请人：UNIV NOTTINGHAM

  公开号：WO2019058132A1

  公开（公告）日：2019-03-28

  This invention relates to compounds that are inhibitors of the CDK12 kinase. The compounds are useful in the treatment of disorders mediated by CDK12 kinase including myotonic dystrophy type 1 (DM1) and other disorders caused by the generation of RNA repeat expansion transcripts. In particular,the invention relates to compounds of the formula (I), or a pharmaceutically acceptable salts or N-oxides thereof, wherein R1a, R2, R3, R4a, R4b and R4c are as defined herein.

  这项发明涉及抑制CDK12激酶的化合物。这些化合物可用于治疗由CDK12激酶介导的疾病，包括1型肌强直性营养不良（DM1）和其他由RNA重复扩展转录物引起的疾病。特别是，该发明涉及公式（I）的化合物，或其药用可接受的盐或N-氧化物，其中R1a, R2, R3, R4a, R4b和R4c按本文定义。
• [EN] SUBSTITUTED ALKYNYLENE COMPOUNDS AS ANTICANCER AGENTS<br/>[FR] COMPOSÉS ALCYNYLÈNE SUBSTITUÉS EN TANT QU'AGENTS ANTICANCÉREUX
  申请人：AURIGENE DISCOVERY TECH LTD

  公开号：WO2019142126A1

  公开（公告）日：2019-07-25

  The present invention relates to substituted alkynylene compounds represented by compound of formula (I) pharmaceutically acceptable salts and stereoisomers thereof. The present invention further provides the methods of preparation of compound of formula (I) and therapeutic uses thereof as anti-cancer agents.

  本发明涉及代表为化合物(I)的取代炔基化合物，其药学上可接受的盐和立体异构体。本发明还提供了化合物(I)的制备方法以及作为抗癌药物的治疗用途。
• Cured film-forming composition
  申请人：NISSAN CHEMICAL CORPORATION

  公开号：US10669376B2

  公开（公告）日：2020-06-02

  Provided are: a cured film-forming composition whereby a underlayer film for image formation formed from the composition exhibits high liquid repellency (lyophobicity) and lyophilic/liquid-repellent properties of the underlayer film can be easily changed even when exposed to a low amount of ultraviolet radiation; and a cured film obtained using the composition. The cured film-forming resin composition is characterized by containing: a polymer comprising a structural unit derived from a first monomer having the structure of formula (1) as component (A); a polymer other than component (A), which is a polymer in which the content of fluorine relative to the overall weight of the polymer is lower than in component (A), as component (B); a photoacid generator as component (C); and a solvent. (In the formula, R1 denotes hydrogen or a methyl group, and R2 denotes a fluorine-containing group able to be detached together with the oxygen atom bonded to R2.)

  提供的是一种治愈的成膜组合物，由该组合物形成的图像形成底层膜表现出高液体排斥性（亲疏性），即使暴露于低量紫外辐射下，底层膜的亲疏性和液体排斥性也可以轻松改变；以及使用该组合物获得的治愈膜。该治愈成膜树脂组合物的特点是包含：作为组分（A）的具有来自第一单体的结构单元的聚合物，该单体的结构式为（1）；除组分（A）外的另一种聚合物，其相对于聚合物总重量的含氟量低于组分（A），作为组分（B）；作为组分（C）的光酸发生剂；和溶剂。（在公式中，R1表示氢或甲基基团，R2表示能够与R2键合的氧原子一起脱落的含氟基团。）
• Negative-working resist composition for electron beams or X-rays
  申请人：FUJI PHOTO FILM CO., LTD.

  公开号：US20020192592A1

  公开（公告）日：2002-12-19

  A negative-working resist composition for electron beams or X-rays comprising (A) a compound generating a sulfonic acid by the irradiation of electron beams or x-rays, (B) a resin which is insoluble in water and soluble in an alkali aqueous solution, (C) a crosslinking agent crosslinking with the resin (B) by the action of an acid, and (D) a compound generating a carboxylic acid having a specific structure by the irradiation of electron beams or x-rays.

  一种用于电子束或X射线的负型光刻胶组合物，包括（A）通过电子束或X射线辐射产生磺酸的化合物，（B）在水中不溶而在碱性水溶液中可溶的树脂，（C）通过酸作用与树脂（B）交联的交联剂，以及（D）通过电子束或X射线辐射产生具有特定结构的羧酸的化合物。
• Acid-functionalized hydrophobic monomer emulsions, latexes, and associated latexes
  申请人：Ganapathiappan Sivapackia

  公开号：US20080182934A1

  公开（公告）日：2008-07-31

  The present invention is drawn to an aqueous emulsion composition. The composition includes an aqueous phase and a hydrophobic phase dispersed in the aqueous phase, which includes a plurality of hydrophobic monomers. The monomers are acid-functionalized and hydrophobic, with less than 10% solubility in water. In one aspect, the monomers can be aromatic. Such monomers can be polymerized with other monomers to form latex particulates. A latex can include latex particulates dispersed in an aqueous fluid medium. In one embodiment, latex particulates can include from about 0.1 wt % to about 25 wt % of polymerized hydrophobic acid-functionalized monomer, and at least one other polymerized film-forming monomer. The latex can be formulated as an ink-jet ink.

  本发明涉及一种水性乳液组合物。该组合物包括水相和分散在水相中的疏水相，其中包括多种疏水单体。这些单体具有酸功能化和疏水性，在水中的溶解度小于10％。在一个方面，这些单体可以是芳香族的。这些单体可以与其他单体聚合形成乳胶微粒。乳胶可以包括分散在水性流体介质中的乳胶微粒。在一个实施例中，乳胶微粒可以包括约0.1重量％至约25重量％的聚合疏水性酸功能化单体，以及至少一种其他聚合成膜单体。该乳胶可以制成喷墨墨水。